Chemotherapy-induced genotoxic stress promotes sensitivity to natural killer cell cytotoxicity by enabling missing-self recognition.
Natural killer (NK) cells can recognize and kill tumor cells lacking "self" markers, such as class I MHC, but the basis for this recognition is not completely understood. NKR-P1 receptors are members of the C-type lectin-related NK receptor superfamily that are conserved from rodents to humans. Identification of Clr ligands for the NKR-P1 receptors has facilitated functional analysis of MHC-independent target cell recognition by NK cells. One receptor-ligand pair, NKR-P1B:Clr-b, can mediate "missing-self" recognition of tumor and infected cells, but the role of this axis in sensing stressed cells remains unknown. Here, we show that Clr-b is rapidly downregulated in cells undergoing genotoxic and cellular stress at the level of both RNA and surface protein. Stress-mediated loss of Clr-b on leukemia cells enhanced cytotoxicity mediated by NKR-P1B(+) NK cells. Notably, Clr-b downregulation was coordinated functionally with stress-mediated upregulation of NKG2D ligands (but not class I MHC). Our findings highlight a unique role for the MHC-independent NKR-P1B:Clr-b missing-self axis in recognition of stressed cells, and provide evidence of two independent levels of Clr-b regulation in stressed cells.
Fine
Jason H
JH
Department of Immunology, University of Toronto, Sunnybrook Research Institute, Toronto, Ontario, Canada.
Chen
Peter
P
Mesci
Aruz
A
Allan
David S J
DS
Gasser
Stephan
S
Raulet
David H
DH
Carlyle
James R
JR
D000818:Animals; D016590:Aphidicolin / Q000494:pharmacology; D064007:Ataxia Telangiectasia Mutated Proteins; D001761:Bleomycin / Q000494:pharmacology; D018797:Cell Cycle Proteins / Q000378:metabolism; D002945:Cisplatin / Q000494:pharmacology; D004249:DNA Damage / Q000187:drug effects / Q000276:immunology*; D004268:DNA-Binding Proteins / Q000378:metabolism; D015536:Down-Regulation; D007694:Killer Cells, Natural / Q000187:drug effects / Q000276:immunology*; D037181:Lectins, C-Type / Q000096:biosynthesis / Q000276:immunology; D008565:Membrane Proteins / Q000096:biosynthesis / Q000276:immunology; D051379:Mice; D041681:NIH 3T3 Cells; D017346:Protein Serine-Threonine Kinases / Q000378:metabolism; D011687:Purines / Q000494:pharmacology; D011971:Receptors, Immunologic / Q000276:immunology; D000077546:Roscovitine; D025521:Tumor Suppressor Proteins / Q000378:metabolism
D018797:Cell Cycle Proteins; D004268:DNA-Binding Proteins; D037181:Lectins, C-Type; D008565:Membrane Proteins; C429003:Ocil protein, mouse; D011687:Purines; D011971:Receptors, Immunologic; D025521:Tumor Suppressor Proteins; D000077546:Roscovitine; D001761:Bleomycin; D016590:Aphidicolin; C576897:Atr protein, mouse; C576324:ATM protein, human; D064007:Ataxia Telangiectasia Mutated Proteins; C576325:Atm protein, mouse; D017346:Protein Serine-Threonine Kinases; D002945:Cisplatin
Blood. 2007 Jul 15;110(2):606-15
17405908
Nature. 2008 Aug 14;454(7206):899-902
18615019
Cancer Res. 2006 Apr 15;66(8):3959-62
16618710
Nature. 1992 Jul 2;358(6381):66-70
1614533
Immunol Rev. 2006 Dec;214:130-42
17100881
J Cell Biol. 2001 Dec 24;155(7):1265-73
11756476
Annu Rev Biochem. 2003;72:395-447
12651740
Nat Immunol. 2003 Aug;4(8):801-7
12858173
Cancer Res. 1999 Sep 1;59(17):4375-82
10485486
Immunity. 2007 May;26(5):617-27
17462921
Proc Natl Acad Sci U S A. 2004 Mar 9;101(10):3527-32
14990792
Nucleic Acids Res. 2004 Apr 01;32(6):1967-72
15060176
J Clin Invest. 2001 Jun;107(12):1599-606
11413168
Nat Immunol. 2008 Sep;9(9):1065-73
18677316
Science. 1999 Sep 10;285(5434):1733-7
10481009
Immunogenetics. 2001 Apr;53(3):209-14
11398965
Cancer Res. 2003 Aug 1;63(15):4396-401
12907610
J Biol Chem. 2007 Mar 9;282(10):6954-64
17182611
J Exp Med. 2009 Feb 16;206(2):287-98
19171762
Science. 2005 Jul 1;309(5731):127-30
15994556
J Biol Chem. 2001 May 4;276(18):14916-23
11278931
J Immunol. 2009 Jul 1;183(1):106-16
19535641
Proc Natl Acad Sci U S A. 1978 Jul;75(7):3327-31
28524
Proc Natl Acad Sci U S A. 2008 Feb 5;105(5):1656-61
18230726
J Exp Med. 1995 May 1;181(5):1911-5
7722466
J Immunol. 2000 Sep 1;165(5):2390-7
10946262
J Biol Chem. 2002 Oct 4;277(40):37124-30
12145276
Trends Cell Biol. 1998 Oct;8(10):397-403
9789328
Int Immunol. 1994 Mar;6(3):369-76
8186188
J Virol. 2007 Feb;81(4):1934-50
17151099
Annu Rev Immunol. 2005;23:225-74
15771571
Leuk Lymphoma. 2002 Aug;43(8):1637-44
12400607
Eur J Immunol. 2005 Feb;35(2):439-48
15682455
Mol Immunol. 2004 Feb;40(12):845-59
14698223
Curr Top Microbiol Immunol. 2006;298:23-57
16329184
Nature. 1986 Feb 20-26;319(6055):675-8
3951539
J Biol Chem. 2003 Sep 26;278(39):37139-45
12847089
Nature. 2005 Aug 25;436(7054):1186-90
15995699
Semin Immunol. 2008 Dec;20(6):321-30
18595730
J Virol. 2008 Oct;82(20):10188-98
18667506
J Cell Biol. 2008 Jul 28;182(2):233-9
18644891
Immunity. 2000 Jun;12(6):721-7
10894171
J Immunol. 1999 May 15;162(10):5917-23
10229828
Biochemistry. 1997 Nov 25;36(47):14418-29
9398160
Immunol Res. 2006;35(1-2):13-26
17003506
J Immunol. 2006 Jun 15;176(12):7511-24
16751398
Science. 2007 Jul 20;317(5836):376-81
17641203
Annu Rev Biochem. 2004;73:39-85
15189136
Semin Immunol. 2006 Jun;18(3):145-50
16740393
Blood. 2009 Apr 9;113(15):3503-11
19098271